Organization
Axsome Therapeutics
20 clinical trials
Clinical trial
A Randomized, Double-blind, Active-controlled Study of AXS-05 for the Prevention of Relapse of Depressive SymptomsStatus: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
A Study to Assess the Long-term Efficacy and Safety of AXS-12 in the Treatment of Cataplexy and Excessive Daytime Sleepiness in Subjects With NarcolepsyStatus: , Estimated PCD: 2024-12-01
Clinical trial
SUNOSI® (Solriamfetol) Pregnancy Registry: An Observational Study on the Safety of Solriamfetol Exposure in Pregnant Women and Their OffspringStatus: Recruiting, Estimated PCD: 2029-09-01
Clinical trial
ADVANCE-2: Addressing Dementia Via Agitation-Centered Evaluation 2: A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Alzheimer's Disease AgitationStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multi- Center Study to Assess the Efficacy and Safety of AXS-12 in the Treatment of Cataplexy and Excessive Daytime Sleepiness in Subjects With NarcolepsyStatus: Completed, Estimated PCD: 2024-03-15
Clinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Solriamfetol in AdultsStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
An Open-Label, Multiple-Dose Evaluation of the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP InhibitorStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease AgitationStatus: , Estimated PCD: 2024-12-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Trial of Solriamfetol in Subjects With Major Depressive DisorderStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Multi-center, Randomized, Double-blind, Placebo-controlled, 3-Week Crossover Study to Assess the Efficacy and Safety of AXS-12 in Subjects With Cataplexy and Excessive Daytime Sleepiness in NarcolepsyStatus: Completed, Estimated PCD: 2019-11-27
Clinical trial
A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects With Dementia of the Alzheimer's TypeStatus: Completed, Estimated PCD: 2020-04-17
Clinical trial
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study (SHARP): a 5-Week Double-blind, Placebo-controlled, Randomized, Crossover, Multicenter Study of Solriamfetol in Improving Cognitive Function in Participants With Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Plus Impaired Cognitive FunctionStatus: Completed, Estimated PCD: 2022-09-19
Clinical trial
An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Major Depressive DisorderStatus: Completed, Estimated PCD: 2020-10-23
Clinical trial
MOMENTUM: A Randomized, Double-blind, Single-dose, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in AdultsStatus: Completed, Estimated PCD: 2019-12-10
Clinical trial
A Phase 4, Open-Label, Single-Dose Study to Evaluate Sunosi® (Solriamfetol) Pharmacokinetics in Breast Milk and Plasma of Healthy Postpartum Women Following Oral Administration of Sunosi®Status: Completed, Estimated PCD: 2022-04-15
Clinical trial
A Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects With Dementia of the Alzheimer's TypeStatus: Completed, Estimated PCD: 2022-11-21
Clinical trial
AXS-05-MDD-301: A Randomized, Double-Blind, Placebo-Controlled Trial of AXS-05 in Subjects With Major Depressive DisorderStatus: Completed, Estimated PCD: 2019-11-26
Clinical trial
An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Treatment Resistant DepressionStatus: Completed, Estimated PCD: 2022-03-04
Clinical trial
An Open-Label, Long-Term Study to Assess the Safety and Efficacy of AXS-07 (MoSEIC™ Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in AdultsStatus: Completed, Estimated PCD: 2020-09-22
Clinical trial
A Phase 3, Randomized, Double-blind, Placebo-Controlled Trial of Solriamfetol in Adults With Binge Eating Disorder (BED)Status: Recruiting, Estimated PCD: 2025-12-01